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STUDY QUESTION: Does assisted reproduction, such as ovarian stimulation and/or laboratory procedures, have impact on perinatal
outcomes of singleton live births compared to natural conception in couples with unexplained subfertility?
SUMMARY ANSWER: Compared to natural conception, singletons born after intrauterine insemination with ovarian stimulation
(IUI-OS) had a lower birthweight, while singletons born after IVF had comparable birthweights, in couples with unexplained subfertility.
WHAT IS KNOWN ALREADY: Singletons conceived by assisted reproduction have different perinatal outcomes such as low
birthweight and a higher risk of premature birth than naturally conceived singletons. This might be due to the assisted reproduction, such
as laboratory procedures or the ovarian stimulation, or to an intrinsic factor in couples with subfertility.
STUDY DESIGN, SIZE, DURATION: We performed a prospective cohort study using the follow-up data of two randomized
clinical trials performed in couples with unexplained subfertility. We evaluated perinatal outcomes of 472 live birth singletons conceived
after assisted reproduction or after natural conception within the time horizon of the studies.
PARTICIPANTS/MATERIALS, SETTING, METHODS: To assess the possible impact of ovarian stimulation we compared the single-
tons conceived after IUI with FSH or clomiphene citrate (CC) and IVF in a modified natural cycle (IVF-MNC) or standard IVF with single
embryo transfer (IVF-SET) to naturally conceived singletons in the same cohorts. To further look into the possible effect of the laboratory
procedures, we put both IUI and IVF groups together into IUI-OS and IVF and compared both to singletons born after natural conception.
We only included singletons conceived after fresh embryo transfers. The main outcome was birthweight presented as absolute weight in
grams and gestational age- and gender-adjusted percentiles. We calculated differences in birthweight using regression analyses adjusted for
maternal age, BMI, smoking, parity, duration of subfertility and child gender.
MAIN RESULTS AND THE ROLE OF CHANCE: In total, there were 472 live birth singletons. Of the 472 singleton pregnancies, 209
were conceived after IUI-OS (136 with FSH and 73 with CC as ovarian stimulation), 138 after IVF (50 after IVF-MNC and 88 after
IVF-SET) and 125 were conceived naturally.
†The members of the INeS and SUPER Study Group are listed in the Appendix.
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Singletons conceived following IUI-FSH and IUI-CC both had lower birthweights compared to naturally conceived singletons (adjusted
difference IUI-FSH 156.3 g, 95% CI 287.9 to 24.7; IUI-CC 160.3 g, 95% CI 316.7 to 3.8). When we compared IVF-MNC and
IVF-SET to naturally conceived singletons, no significant difference was found (adjusted difference IVF-MNC 75.8 g, 95% CI 102.0 to
253.7; IVF-SET 10.6 g, 95% CI 159.2 to 138.1). The mean birthweight percentile was only significantly lower in the IUI-FSH group
(7.0 percentile, 95% CI 13.9 to 0.2). The IUI-CC and IVF-SET group had a lower mean percentile and the IVF-MNC group a higher
mean percentile, but these groups were not significant different compared to the naturally conceived group (IUI-CC 5.1 percentile,
95% CI 13.3 to 3.0; IVF-MNC 4.4 percentile, 95% CI 4.9 to 13.6; IVF-SET 1.3 percentile, 95% CI 9.1 to 6.4).
Looking at the laboratory process that took place, singletons conceived following IUI-OS had lower birthweights than naturally conceived
singletons (adjusted difference 157.7 g, 95% CI 277.4 to 38.0). The IVF group had comparable birthweights with the naturally
conceived group (adjusted difference 20.9 g, 95% CI 110.8 to 152.6). The mean birthweight percentile was significantly lower in the
IUI-OS group compared to the natural group (6.4 percentile, 95% CI 12.6 to 0.1). The IVF group was comparable (0.7 percentile,
95% CI 6.1 to 7.6).
LIMITATIONS, REASONS FOR CAUTION: The results are limited by the number of cases. The data were collected prospectively
alongside the randomized controlled trials, but analyzed as treated.
WIDER IMPLICATIONS OF THE FINDINGS: Our data suggest IUI in a stimulated cycle may have a negative impact on the birth-
weight of the child and possibly on pre-eclampsia. Further research should look into the effect of different methods of ovarian stimulation
on placenta pathology and pre-eclampsia in couples with unexplained subfertility using naturally conceived singletons in the unexplained
population as a reference.
STUDY FUNDING/COMPETING INTEREST(S): Both initial trials were supported by a grant from ZonMW, the Dutch Organization
for Health Research and Development (INeS 120620027, SUPER 80-83600-98-10192). The INeS study also had a grant from
Zorgverzekeraars Nederland, the Dutch association of healthcare insurers (09-003). B.W.J.M. is supported by an NHMRC investigator
Grant (GNT1176437) and reports consultancy for ObsEva, Merck Merck KGaA, Guerbet and iGenomix, outside the submitted
work. A.H. reports grants from Ferring Pharmaceutical company (the Netherlands), outside the submitted work. F.J.M.B. receives
monetary compensation as a member of the external advisory board for Merck Serono (the Netherlands), Ferring Pharmaceutics BV
(the Netherlands) and Gedeon Richter (Belgium), he receives personal fees from educational activities for Ferring BV (the Netherlands)
and for advisory and consultancy work for Roche and he receives research support grants from Merck Serono and Ferring Pharmaceutics
BV, outside the submitted work. The remaining authors have nothing to disclose.
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Introduction
Up to a quarter of all couples who are unable to conceive after
12 months of unprotected intercourse, and where routine fertility
investigations show no abnormalities are diagnosed with unexplained
subfertility (Tjon-Kon-Fat et al., 2016). These couples are treated with
either intrauterine insemination with ovarian stimulation (IUI-OS) or
IVF. The 18th ESHRE report on assisted reproduction shows that in
the year 2014 a total of 120 789 IUI cycles and 146 148 IVF cycles
were performed in 39 European countries (De Geyter et al., 2018), so
both treatments are widely used. The prediction model of Hunault
can be used in these couples with unexplained subfertility to differenti-
ate between couples that have favorable chances of conceiving natu-
rally and those that do not. The model is an externally validated
synthesis model and includes female age, duration of subfertility, sperm
motility, a previous pregnancy and referral status to contribute in the
shared decision-making process when choosing the best treatment op-
tion. In couples with the 1-year prognosis to conceive naturally below
30%, assisted reproduction may improve efficacy but solid evidence is
missing (Hunault et al., 2004; Wang et al., 2019). Notably, many cou-
ples still conceive naturally in between treatment cycles (van Eekelen
et al., 2018). To decide which strategy is preferred; i.e. either continue
with expectant management or start with IUI or proceed directly to
IVF, safety aspects should also be taken into account.
Initial concerns about the safety of IVF were mainly attributed to a
higher rate of multiple births (Pinborg et al., 2004). The trend toward
single embryo transfer (SET) to prevent multiple pregnancies de-
creased the number of perinatal complications from assisted reproduc-
tion (Kallen et al., 2010). Yet, large observational studies have shown
that singletons born after different types of assisted reproduction still
have different perinatal outcomes such as lower birthweight (LBW)
and a higher risk of being born premature compared to naturally con-
ceived singletons (Pinborg et al., 2013; Dunietz et al., 2015). As these
studies usually compared perinatal outcomes of singletons in subfertile
couples to fertile couples, it remains difficult to determine whether
these perinatal outcomes are assisted reproduction procedures re-
lated, or the result of a possible intrinsic factor in the subfertile couples
(Pandey et al., 2012; Ombelet et al., 2016).
Several causes of the different perinatal outcomes of singletons fol-
lowing assisted reproduction have been put forward. First, the ovarian
stimulation could be a potential risk factor for abnormal placentation
leading to lower birthweights (Pereira et al., 2015). Second, the labora-
tory procedures of assisted reproduction appear to increase the risks
(Lambert, 2003). Third, subfertile couples may have an intrinsic higher
risk of adverse perinatal outcomes (Pelinck et al., 2010; Messerlian
et al., 2013).
To overcome the intrinsic effect of subfertility, the outcomes after
assisted reproduction and naturally conceived children should be
































































































evaluated within the unexplained subfertile population. As we know of
this comparison has not been reported yet and the current study
could be a contribution to the scientific literature. We evaluated in a
population of couples with unexplained subfertility if ovarian stimula-
tion and/or artificial laboratory procedures affected perinatal out-
comes of the live born singletons compared to natural conception in
the same cohort, therefore leaving the intrinsic factor of subfertile cou-
ples out of the equation.
Materials and methods
Study design
We performed a prospective cohort study using the follow-up data of
two randomized clinical trials (RCT) in couples with unexplained sub-
fertility and mild male subfertility (INeS trial NTR 939, SUPER study
NTR 4057). Both the initial trials were approved by the medical
Ethical Committee of the Academic Medical Centre and the Central
Committee on Research involving Human Subjects (CCMO) (INeS:
NL12782.018.07; Super: NL 43131-018-13). Participants provided
written informed consent for use of the follow-up data during entry in
both the RCTs.
The INeS trial was a Dutch multicenter randomized controlled non-
inferiority trial, they included 602 couples and compared the effective-
ness of IUI-OS, modified natural cycle IVF (IVF with monofolliculair
growth using a GnRH antagonist and gonadotropins when follicle dom-
inance occurred) (IVF-MNC), and standard IVF with controlled hyper-
stimulation and SET (IVF-SET) (Bensdorp et al., 2015). The SUPER
study was a Dutch multicenter randomized controlled superiority trial,
they included 738 women and compared the effectiveness of IUI with
FSH versus clomiphene citrate (CC) (Danhof et al., 2018). The pri-
mary outcomes were healthy singletons (INeS trial) and ongoing preg-
nancies (SUPER study).
Study population
Both RCTs included couples diagnosed with unexplained or mild male
subfertility. Unexplained subfertility was defined as a failure to conceive
after 1 year of regular unprotected intercourse where fertility investiga-
tions showed an ovulatory cycle and at least one patent fallopian tube.
Mild male subfertility was described as a prewash total motile sperm
count of a least 3 million. Only couples with an unfavorable prognosis,
defined as a 12-month prognosis at natural conception according to
the model of Hunault lower than 30%, were included (Hunault et al.,
2004). Both trials excluded women with anovulation, double-sided
tubal disease, polycystic ovarian syndrome and other endocrine dis-
eases at baseline (such as Cushing’s syndrome or diabetes mellitus
type I). The INeS study also excluded women with severe endometri-
osis, premature ovarian failure and women older than 38 years. The
SUPER trial excluded women older than 43 years. We only included
the singletons conceived after fresh embryo transfers.
Outcomes
The main outcome is birthweight presented as absolute weight in
grams and gestational age- and gender-adjusted percentiles. Other
outcomes were LBW (birthweight <2500 g), very LBW (birthweight
<1500 g), small for gestational age (SGA) (birthweight <10th and
<3rd of the national reference), high birthweight (birthweight
>4000 g), large for gestation age (birthweight >90th centile of the na-
tional reference), preterm birth (delivery <37, <32 and <28 weeks of
gestation) split up in iatrogenic or spontaneous, congenital anomalies
and pre-eclampsia.
We assessed the possible impact of ovarian stimulation by compar-
ing the singletons conceived after IUI with FSH or CC and IVF-MNC
or IVF-SET to naturally conceived singletons in the same cohorts. To
further look into the possible effect of the laboratory procedures, we
put both IUI and IVF groups together into IUI-OS and IVF. Then we
compared both groups to singletons born after natural conception
during the study period.
To compare the birthweights in our study with the birthweights of
singleton live births from the general Dutch population, we calculated
gestational age- and gender-adjusted percentiles based on the Dutch
reference curves. These birthweight percentiles allow us to evaluate
birth weight independent of gestational age and gender. The Dutch
reference curves are based on a low-risk population (infants with one
or more risk factors for abnormal fetal growth were excluded) and in-
cluded 1 629 776 live birth singleton infants (2000–2014) (Hoftiezer
et al., 2019).
Statistical analysis
Continuous variables were expressed as mean § standard deviation
and categorical variables were expressed as number and percentage.
We performed our primary analysis on basis of the as-treated popula-
tion, grouped as IUI-FSH, IUI-CC, IVF-MNC, IVF-SET and natural con-
ception. (The intention to treat numbers as retrieved from the INeS
and SUPER trial are available in Supplementary Tables SI and SII.) For
all analyses, the naturally conceived singletons were the control group.
We assessed the impact of ovarian stimulation and laboratory pro-
cedures on the birthweight of a singleton, by using linear regression
analyses with adjustment for maternal age, pre-conception BMI, smok-
ing, parity, subfertility length and child gender. The decision to enter
these factors was made a priori based on the known influence on
birthweight. The binary outcomes were compared using Fisher Exact.
P-values below 0.05 are considered as statistically significant differen-
ces. We used SPSS (version 25.0) for all statistical analyses.
Results
In total, both trials reported 541 ongoing pregnancies. We excluded
36 multiple gestations (12 in the IVF group and 23 in the IUI-OS
group). Twenty-five women with an ongoing singleton pregnancy were
lost to follow-up. Eight women had no live birth between 17 and
37 weeks of gestation, no further information is available. Of the
remaining 472 live birth singletons, 136 were conceived after IUI-FSH,
73 after IUI-CC, 50 after IVF-MNC, 88 after IVF-SET and 125 were
conceived naturally. We summarized the study sample in a flowchart
(Fig. 1). The baseline characteristics are depicted in Table I. The IVF-
SET group differs significantly in pre-conception BMI and duration of
subfertility, the IUI-FSH group was more primary subfertile compared
to the naturally conceived group.




















































First we compared the birthweights in the different ovarian stimulation
groups to natural conception adjusted for age, BMI, smoking, parity,
subfertility length and child gender. The mean birthweights were lower
in both the IUI-FSH and IUI-CC groups when compared to the natu-
rally conceived group, after adjustment, the difference remained signifi-
cant (adjusted difference IUI-FSH 156.3 g, 95% CI 287.9 to 24.7;
IUI-CC 160.3 g, 95% CI 316.7 to 3.8). The mean birthweights
following IVF-MNC and IVF-SET were not significantly different com-
pared to the naturally conceived group (adjusted difference IVF-MNC
75.8 g, 95% CI 102.0 to 253.7; IVF-SET 10.6 g, 95% CI 159.2 to
138.1) (Table II).
We subsequently compared the birthweights of the groups based
on the laboratory procedures that took place. The birthweight of sin-
gletons born after IUI-OS was lower than in the naturally conceived
group (adjusted difference 157.7 g, 95% CI 277.4 to 38.0). The
mean birthweight in the IVF group was comparable to the naturally
conceived group (adjusted difference 20.9 g, 95% CI 110.8 to 152.6)
(Table III).
>Percentiles
We compared the birthweights of our singletons to singletons in the
low-risk Dutch population by calculating the gestational age- and
gender-adjusted percentiles. We found a significant lower birthweight
percentile following IUI-FSH compared to natural conception (mean
difference 7.0 percentile, 95% CI 13.9 to 0.2) while in the IUI-
CC group the difference was not significant (mean difference 5.1
percentile, 95% CI 13.3 to 3.1). The birthweight percentiles for
singletons born after IVF-MNC and IVF-SET were comparable with
singletons born after natural conception, which is almost average
(Tables II and III, Supplementary Figs S1 and S2).
Other outcomes
With respect to ovarian stimulation, the IUI-FSH group had significantly
more mothers with pre-eclampsia during their pregnancy compared to
the naturally conceived group (8.6% vs. 2.6% P¼ 0.05). Six of the 17
mothers who suffered from pre-eclampsia had an SGA singletons. In
total, 46 singletons were conceived with donor semen. One of these
mothers developed pre-eclampsia, she conceived after IUI-FSH and
had a singleton with a normal birthweight.
The IUI-CC group had the most singletons with very LBW (5.5%
vs. 0.8% P¼ 0.04) compared to naturally conceived singletons. Of the
singletons conceived after IUI-FSH and IUI-CC a significantly smaller
number were born with very high birthweight compared to natural
conception (6.7% and 5.5% vs. 15.2%, P¼ 0.03 and P¼ 0.04)
(Table II).
When comparing the laboratory procedures, the IUI procedure
resulted in less very high birthweight (>4000 g) when compared to
natural (6.3% vs. 15.2%, P¼ 0.01). We found no differences between
IVF and natural conception (Table III).
Twenty-eight women had a preterm delivery before 37 weeks. In 16
women (57.1%), the onset of premature labor was spontaneous and
started with contractions (n¼ 10) or preterm premature rupture of
membranes PPROM[AQ: Please spell out PPROM (if necessary).] fol-
lowed by natural contractions (n¼ 6). We considered the other
Figure 1. Study flowchart. IUI-CC, intrauterine insemination with clomiphene citrate; IUI-FSH, intrauterine insemination with follicle stimulating
hormone; IUI-OS, intrauterine insemination with ovarian stimulation; IVF-MNC, IVF in a modified natural cycle; IVF-SET, standard IVF with single
embryo transfer.



























































..premature births (n¼ 12/28; 42.9%) as ‘iatrogenic’ since the onset
was not spontaneous but the result of a decision by the clinician on
various indications (i.e. indicated primary cesarean section (n¼ 7) or
indicated induction of labor (n¼ 5)). There were no women with
PPROM in the iatrogenic group. The distribution with details on pre-
term birth over the different treatment groups can be found in
Tables II and III.
Congenital anomalies
There were five cases of congenital anomalies that we classified
according to the ICD-10 classification (international classification of dis-
eases, 10th revision). There were two cases of esophageal atresia
(Q39) in the IUI-FSH group. One case of Aicardi syndrome (Q4) oc-
curred in the IUI-CC group. In the IVF-MNC group, one case of
Moebius syndrome (Q87) occurred and in the IVF-SET group, one
case of Down syndrome (Q90) occurred. None of the naturally con-
ceived singletons had congenital anomalies. We performed a linear re-
gression analyses with adjustment for congenital anomalies. The mean
difference in birthweight remained significantly lower in the IUI-FSH
and IUI-CC groups compared to naturally conceived singletons (ad-
justed difference IUI-FSH 153.4 g, 95% CI 281.0 to 25.9; IUI-CC
166.8 g, 95% CI 318.4 to 15.2) and in the IVF-MNC and IVF-
SET groups the mean birthweights were comparable to naturally con-
ceived singletons (adjusted difference IVF-MNC 67.0 g, 95% CI 105.2
to 239.3; IVF-SET 11.3 g, 95% CI 154.4 to 131.8).
Discussion
We evaluated whether ovarian stimulation or laboratory procedures
in assisted reproduction affected the perinatal outcomes of singleton
live births in couples with unexplained subfertility. Singletons conceived
following IUI-OS had between 38 and 280 g lower birthweights than
naturally conceived singletons. The observed birthweight difference
was irrespective of whether FSH or CC was used. The difference in
birthweight was reflected by more very low birthweight (<1500 g) and
less very high birthweight (>4000 g) in singletons conceived by IUI-OS
than in natural conceptions. Singletons conceived by IVF, whether IVF-
MNC or IVF-SET, did not have lower birthweights compared to natu-
rally conceived singletons in unexplained subfertile couples. These
results were confirmed when calculating the birthweight percentile rel-
ative to the low-risk Dutch reference population of singletons.
Based on literature, we expected to find lower birthweights in both
the IUI-OS and IVF group compared to natural conception (Berntsen
et al., 2019). However, these studies compared children conceived af-
ter assisted reproduction with children conceived after natural concep-
tion from fertile populations. Studies which did look at subfertile
couples did not only included couples with unexplained subfertility
(Pelinck et al., 2010). This may explain why we found no indication for
a lower birthweight following IVF. Because, in contrast to most studies,
we excluded couples with other causes of subfertility such as polycys-
tic ovary syndrome or other endocrine disorders which maybe influ-
ence birthweight (Messerlian et al., 2013). This theory is supported by
data from Isaksson et al. (2002), a case control study where the peri-
natal outcomes of singletons born in couples with unexplained subfer-
tility who conceived after IVF/ICSI were compared to perinatal
outcomes of singletons born in couples without subfertility who con-
ceived naturally. There was no difference in mean birthweight between
both groups in this study. The overall perinatal outcomes of singletons
among couples with unexplained subfertility treated with IVF/ICSI
were similar to the perinatal outcomes of singletons born after natural
conception in couples without fertility problems (Isaksson et al., 2002).
The strengths of our study are that firstly we only used live birth sin-
gletons in our comparisons and secondly the studied population was
homogenous in that all the included couples shared the same profile
and suffered from unexplained subfertility with poor chances on
............................................................................................................................................................................................................................











Age in years 32.67 (3.5) 32.82 ( 3.4) 33.51 (2.9) 32.8 (3.4) 32.75 (3.6)
BMI in kg/m2a 24.7 (4.2) 24.4 (3.8) 23.1 (3.3) 23.0 (3.3)* 24.0 (4.2 )
Duration subfertility in monthsb 34.7 (16.0) 28.1 (11.8) 30.8 (9.2) 36.6 (15.8)* 31.8 (14.2)
Smoking
Yes 26 (19.1) 9 (12.3) 6 (12.0) 22 (20.2) 23 (18.4)
No 110 (80.9) 64 (87.7) 44 (88.0) 87 (78.8) 102 (81.6)
Primary subfertility
Yes 120 (88.2)þ 59 (80.8) 39 (78.0) 86 (78.9) 93 (74.4)
No 16 (11.8) 14 (19.2) 11 (22.0) 23 (21.1) 32 (25.6)
Total motile sperm count (106) 72.1 (69.0) 84.0 (113.8) 86.6 (97.1) 79.5 (95.2) 73.0 (72.2)
Data are n (%) or mean (SD).
*Linear regression analyses P< 0.05 compared to natural.
þChi-square test P< 0.05 compared to natural.
an¼ 459.
bn¼ 469.
IUI-CC, intrauterine insemination with clomiphene citrate; IUI-FSH, intrauterine insemination with FSH; IVF-MNC, IVF in a modified natural cycle; IVF-SET, standard IVF with single
embryo transfer.




























conceiving naturally within 12 months after fertility work-up according
to the model of Hunault (Hunault score <30%). A limitation of this
study is that the power of this study is relatively low due to the rather
small numbers of cases, so the results have to be interpreted with cau-
tion. A second limitation of this study is that we were not able to ad-
just for other confounding factors such as high blood pressure,
gestational diabetes mellitus or paternal characteristics because these
variables were not selected for collection in the case record forms of
the original trials. Nevertheless, we found no evidence in our study to
suggest a clinically important reduction in birthweight due to IVF in the
population of unexplained subfertility. Whether the FSH or CC or the
IUI process truly has a negative impact on birthweight needs to be in-
vestigated further.
We observed a relatively high number of women who devel-
oped pre-eclampsia in the IUI-FSH group. This might be a chance
finding as the expected incidence of pre-eclampsia is low and the
number of singletons in our study was limited. In a previous retro-
spective cohort study, there was no evidence for an association
between IUI and pre-eclampsia in a general subfertile population
(Chen et al., 2009). Women conceiving with donor semen might
have a higher risk of pre-eclampsia compared to partners semen
(Gonzalez-Comadran et al., 2014). In our study, we did not find
this.
............................................................................................................................................................................................................................












Mean birthweight in grams (SD) 3296 (492) 3283 (667) 3515 (465) 3439 (418) 3453 (548)
Mean birthweight difference compared










Adjusted mean birthweight difference










Mean birthweight percentile (SD)a 42.4 (27.4) 44.3 (29.9) 53.8 (28.0) 48.1 (27.8) 49.4 (28.5)











Mean gestational age in weeks (SD) 39.3 (2.0) 39.1 (2.5) 39.3 (1.4) 39.2 (1.4) 39.4 (2.0)
n (%) n (%) n (%) n (%) n (%)
Infant sex
Male 59 (43.4) 40 (54.8) 19 (38.0) 45 (51.1) 64 (51.2)
Female 77 (56.6) 33 (45.2) 31 (62.0) 43 (48.9) 61 (48.8)
SGA (<p10) 17 (12.6) 10 (13.7) 4 (8.0) 6 (6.8) 15 (12.0)
SGA (<p3) 4 (3.0) 5 (6.8) 1 (2.0) 1 (1.1) 3 (2.4)
Low birthweight (<2500 g) 5 (3.7) 7 (9.6) 1 (2.0) 2 (2.3) 7 (5.6)
Very low birthweight (<1500 g) 2 (1.5) 4 (5.5)þ 0 (0.0) 0 (0.0) 1 (0.8)
Preterm birth (<37 w) 9 (6.6) 8 (11.0) 2 (4.0) 3 (3.4) 6 (4.8)
Iatrogenic 4 (44.4) 3 (37.5) 2 (100.0) 1 (33.3) 2 (33.3)
Spontaneous 5 (55.6) 5 (62.5) 0 (0.0) 2 (66.7) 4 (66.7)
Preterm birth (<32 w) 2 (1.5) 3 (4.1) 0 (0.0) 0 (0.0) 2 (1.6)
Iatrogenic 0 (0.0) 2 (66.7) 1 (50.0)
Spontaneous 2 (100.0) 1 (33.3) 1 (50.0)
Preterm birth (<28 w) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.8)
Iatrogenic 1 (100.0)
Spontaneous 0 (0.0)
High birthweight (>4000 g) 9 (6.7)þ 4 (5.5)þ 6 (12.0) 7 (8.0) 19 (15.2)
LGA (>p90) 5 (3.7) 5 (6.8) 5 (10.0) 8 (9.1) 9 (6.9)
Congenital anomalies 2 (1.5) 1 (1.4) 1 (2.0) 1 (1.1) 0 (0.0)
Pre-eclampsiab 10 (8.6)c,þ 1 (1.6) 2 (4.0) 1 (1.1) 3 (2.6)
aGestational age- and gender-adjusted percentile based on the Dutch reference curve (Hoftiezer et al., 2019).
bn¼ 452.
cOne woman conceived with donor semen.
*Linear regression analyses P< 0.05 compared to natural.
þChi-square test P< 0.05 compared to natural.


























..It is unclear by what mechanism ovarian stimulation might influence
birthweight. The general theory is that high estradiol concentrations
can play a role, which can cause a negative effect on angiogenesis and
placentation (Pereira et al., 2015). We do not have data of the estra-
diol levels during stimulation, based on literature, we expect the estra-
diol levels to be higher in the IVF-SET group because this corresponds
to the number of follicles which we expect to be highest in the IVF-SET
group. This means that estradiol levels are probably not an explanation
for the lower birthweights in the IUI-OS group (Joo et al., 2010).
The only laboratory process that takes place during IUI treatments
is processing semen. To our knowledge, there is no literature available
that studied the influence of processed semen on perinatal outcomes
of singletons. Processing of semen also takes place at IVF and since we
have not found a different mean birthweight in the IVF group com-
pared to naturally conceived singletons we believe that processing se-
men and the in-vitro procedure do not affect the perinatal outcomes of
singletons.
A possible explanation for the lower birthweight in the IUI-OS
group might be vanishing twins. The remaining fetus after a vanishing
twin has an increased risk for a lower birthweight and being born pre-
mature (Magnus et al., 2017). In the absence of viable twin pregnan-
cies, the development of multiple follicles in IUI-OS might still have
resulted in vanishing twins, while vanishing twins are not to be
expected following IVF-SET.
............................................................................................................................................................................................................................







Mean birthweight in grams (SD) 3291 (558) 3467 (436) 3453 (548)







Adjusted mean birthweight difference






Mean birthweight percentilea (SD) 43.1 (28.2) 50.2 (27.9) 49.4 (28.5)







Mean gestational age in weeks (SD) 39.2 (2.2) 39.3 (1.4) 39.4 (2.0)
n (%) n (%) n (%)
Infant sex
Male 99 (47.4) 64 (46.4) 64 (51.2)
Female 110 (52.6) 74 (53.6) 61 (48.8)
SGA (<p10) 27 (13.0) 10 (7.2) 15 (12.0)
SGA (<p3) 9 (4.3) 2 (1.4) 3 (2.4)
Low birthweight (<2500 g) 12 (5.8) 3 (2.2) 7 (5.6)
Very low birthweight (<1500 g) 6 (2.9) 0 (0.0) 1 (0.8)
Preterm birth (<37 w) 17 (8.6) 5 (3.6) 6 (4.8)
Iatrogenic 7 (41.2) 3 (60.0) 2 (33.3)
Spontaneous 10 (58.8) 2 (40.0) 4 (66.7)
Preterm birth (<32 w) 5 (2.4) 0 (0.0) 2 (1.6)
Iatrogenic 2 (40.0) 1 (50.0)
Spontaneous 3 (60.0) 1 (50.0)
Preterm birth (<28 w) 0 (0.0) 0 (0.0) 1 (0.8)
Iatrogenic 1 (100.0)
Spontaneous 0 (0.0)
High birthweight (>4000 g) 13 (6.3)þ 13 (9.4) 19 (15.2)
LGA (>p90) 10 (4.8) 13 (9.4) 9 (7.2)
Congenital anomalies 3 (1.4) 2 (1.4) 0 (0.0)
Pre-eclampsiab 11 (6.2)c 3 (2.2) 3 (2.6)
aGestational age- and gender-adjusted percentile based on the Dutch reference curve (Hoftiezer et al., 2019).
bn¼ 452.
cOne woman conceived with donor semen.
*Linear regression analyses P< 0.05 compared to natural.
þChi-square test P< 0.05 compared to natural.
IUI-OS, intrauterine insemination with ovarian stimulation; IVF, standard IVF with single embryo transfer; LGA, large for gestational age; SGA, small for gestational age.

































































































In conclusion, in singletons of couples with unexplained subfertility, we
found lower mean birthweights when conception occurred after IUI-
OS (irrespective of FSH or CC was used as ovarian stimulation) com-
pared to natural conception. The singletons also had a lower mean
birthweight than the singletons of the low-risk Dutch population. Our
study suggests that in couples with unexplained subfertility, IVF results
in comparable birthweights and other perinatal outcomes of singletons
when compared to natural conception. Further large prospective co-
hort studies in an unexplained subfertile population are required to
substantiate these findings.
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